Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
62
EVER Quote, Financials, Valuation and Earnings
Last price:
$24.76
Seasonality move
:
13.72%
Day range:
$24.66 - $25.20
52-week range:
$17.35 - $30.03
Dividend yield:
0%
P/E ratio:
17.30x
P/S ratio:
1.44x
P/B ratio:
5.09x
Volume:
397.6K
Avg. volume:
367.5K
1-year change:
33.62%
Market cap:
$890.3M
Revenue:
$500.2M
EPS (TTM):
$1.43
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $346.9M | $418.5M | $404.1M | $287.9M | $500.2M | |
| Revenue Growth (YoY) | 39.44% | 20.63% | -3.44% | -28.76% | 73.73% | |
| Cost of Revenues | $21.4M | $23.9M | $24M | $22.5M | $20.9M | |
| Gross Profit | $325.6M | $394.6M | $380.1M | $265.5M | $479.3M | |
| Gross Profit Margin | 93.84% | 94.28% | 94.07% | 92.2% | 95.82% | |
| R&D Expenses | $29.7M | $35.7M | $31.7M | $27.6M | $29.6M | |
| Selling, General & Admin | $305.3M | $379.7M | $377.4M | $266.4M | $418M | |
| Other Inc / (Exp) | -$2M | -$1.1M | $4.2M | -$23.4M | $178K | |
| Operating Expenses | $335M | $415.4M | $409.1M | $294M | $447.5M | |
| Operating Income | -$9.4M | -$20.9M | -$28.9M | -$28.6M | $31.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$11.2M | -$21.9M | -$24.4M | -$50.7M | $34M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$2.5M | -- | $577K | $1.8M | |
| Net Income to Company | -$11.2M | -$19.4M | -$24.4M | -$51.3M | $32.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$11.2M | -$19.4M | -$24.4M | -$51.3M | $32.2M | |
| Basic EPS (Cont. Ops) | -$0.41 | -$0.67 | -$0.77 | -$1.54 | $0.92 | |
| Diluted EPS (Cont. Ops) | -$0.41 | -$0.67 | -$0.77 | -$1.54 | $0.88 | |
| Weighted Average Basic Share | $27.3M | $29.1M | $31.6M | $33.4M | $35M | |
| Weighted Average Diluted Share | $27.3M | $29.1M | $31.6M | $33.4M | $36.6M | |
| EBITDA | -$6.1M | -$15.8M | -$23.1M | -$22.4M | $37.4M | |
| EBIT | -$9.4M | -$20.9M | -$28.9M | -$28.6M | $31.8M | |
| Revenue (Reported) | $346.9M | $418.5M | $404.1M | $287.9M | $500.2M | |
| Operating Income (Reported) | -$9.4M | -$20.9M | -$28.9M | -$28.6M | $31.8M | |
| Operating Income (Adjusted) | -$9.4M | -$20.9M | -$28.9M | -$28.6M | $31.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $107.6M | $103.2M | $55M | $144.5M | $173.9M | |
| Revenue Growth (YoY) | 19.55% | -4.04% | -46.71% | 162.73% | 20.35% | |
| Cost of Revenues | $6M | $5.9M | $6.2M | $5.5M | $4.7M | |
| Gross Profit | $101.6M | $97.3M | $48.9M | $139.1M | $169.2M | |
| Gross Profit Margin | 94.43% | 94.31% | 88.82% | 96.23% | 97.29% | |
| R&D Expenses | $9.3M | $7.8M | $6.3M | $8M | $7.9M | |
| Selling, General & Admin | $99.3M | $96.2M | $52.2M | $119.4M | $143.7M | |
| Other Inc / (Exp) | -$825K | $122K | -$19.7M | $53K | -- | |
| Operating Expenses | $108.5M | $104M | $58.5M | $127.4M | $151.7M | |
| Operating Income | -$7M | -$6.7M | -$9.7M | $11.7M | $17.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$7.8M | -$6.5M | -$29M | $12.3M | $18.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$2.5M | -- | $236K | $719K | -$345K | |
| Net Income to Company | -$5.3M | -$6.5M | -$29.2M | $11.6M | $18.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$5.3M | -$6.5M | -$29.2M | $11.6M | $18.9M | |
| Basic EPS (Cont. Ops) | -$0.18 | -$0.20 | -$0.87 | $0.33 | $0.52 | |
| Diluted EPS (Cont. Ops) | -$0.18 | -$0.20 | -$0.87 | $0.31 | $0.50 | |
| Weighted Average Basic Share | $29.3M | $32M | $33.5M | $35.2M | $36.2M | |
| Weighted Average Diluted Share | $29.3M | $32M | $33.5M | $37.2M | $37.7M | |
| EBITDA | -$5.7M | -$5.3M | -$7.4M | $13.3M | $18.4M | |
| EBIT | -$7M | -$6.7M | -$9.7M | $11.7M | $17.5M | |
| Revenue (Reported) | $107.6M | $103.2M | $55M | $144.5M | $173.9M | |
| Operating Income (Reported) | -$7M | -$6.7M | -$9.7M | $11.7M | $17.5M | |
| Operating Income (Adjusted) | -$7M | -$6.7M | -$9.7M | $11.7M | $17.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $413.7M | $417.9M | $320.5M | $408.4M | $644.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $23.4M | $24.1M | $23.5M | $20.5M | $20.4M | |
| Gross Profit | $390.3M | $393.8M | $297M | $388M | $624.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $35M | $33.1M | $29.1M | $27.9M | $30.8M | |
| Selling, General & Admin | $369.8M | $389.9M | $297.7M | $347.2M | $533.5M | |
| Other Inc / (Exp) | -$2.8M | $4.7M | -$24.1M | $184K | -- | |
| Operating Expenses | $404.8M | $423.1M | $326.8M | $375M | $564.3M | |
| Operating Income | -$14.5M | -$29.3M | -$29.8M | $12.9M | $60M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$17.2M | -$24.4M | -$52.8M | $14.9M | $55M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$2.5M | -- | $600K | $1.4M | $1.1M | |
| Net Income to Company | -$14.7M | -$24.4M | -$53.4M | $13.5M | $53.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$14.7M | -$24.4M | -$53.4M | $13.5M | $53.9M | |
| Basic EPS (Cont. Ops) | -$0.51 | -$0.79 | -$1.61 | $0.38 | $1.50 | |
| Diluted EPS (Cont. Ops) | -$0.51 | -$0.79 | -$1.61 | $0.35 | $1.43 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$9.7M | -$23.5M | -$23.2M | $18.1M | $64.5M | |
| EBIT | -$14.5M | -$29.3M | -$29.8M | $12.9M | $60M | |
| Revenue (Reported) | $413.7M | $417.9M | $320.5M | $408.4M | $644.7M | |
| Operating Income (Reported) | -$14.5M | -$29.3M | -$29.8M | $12.9M | $60M | |
| Operating Income (Adjusted) | -$14.5M | -$29.3M | -$29.8M | $12.9M | $60M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $316.4M | $315.8M | $232.2M | $352.7M | $497.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $17.8M | $17.9M | $17.5M | $15.5M | $14.9M | |
| Gross Profit | $298.7M | $297.9M | $214.7M | $337.2M | $482.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $26.9M | $24.3M | $21.6M | $21.9M | $23.2M | |
| Selling, General & Admin | $284.3M | $294.5M | $214.9M | $295.6M | $411.1M | |
| Other Inc / (Exp) | -$1.1M | $4.8M | -$23.4M | $154K | -$8.3M | |
| Operating Expenses | $311.1M | $318.8M | $236.5M | $317.5M | $434.3M | |
| Operating Income | -$12.4M | -$20.9M | -$21.8M | $19.7M | $47.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$13.5M | -$15.9M | -$44.3M | $21.3M | $42.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$2.5M | -- | $600K | $1.4M | $702K | |
| Net Income to Company | -$11M | -$15.9M | -$44.9M | $19.9M | $41.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$11M | -$15.9M | -$44.9M | $19.9M | $41.6M | |
| Basic EPS (Cont. Ops) | -$0.38 | -$0.51 | -$1.35 | $0.57 | $1.15 | |
| Diluted EPS (Cont. Ops) | -$0.38 | -$0.51 | -$1.35 | $0.54 | $1.10 | |
| Weighted Average Basic Share | $86.6M | $94.1M | $99.6M | $104.5M | $108.4M | |
| Weighted Average Diluted Share | $86.6M | $94.1M | $99.6M | $109.5M | $113.4M | |
| EBITDA | -$8.8M | -$16.6M | -$16.7M | $23.8M | $50.9M | |
| EBIT | -$12.4M | -$20.9M | -$21.8M | $19.7M | $47.9M | |
| Revenue (Reported) | $316.4M | $315.8M | $232.2M | $352.7M | $497.2M | |
| Operating Income (Reported) | -$12.4M | -$20.9M | -$21.8M | $19.7M | $47.9M | |
| Operating Income (Adjusted) | -$12.4M | -$20.9M | -$21.8M | $19.7M | $47.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $42.9M | $34.9M | $30.8M | $38M | $102.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $46.1M | $35.7M | $43.1M | $25.5M | $64.4M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $4.6M | -- | -- | -- | -- | |
| Other Current Assets | -- | $4.9M | $7M | $5.8M | $5.3M | |
| Total Current Assets | $97.4M | $84.7M | $81M | $69.2M | $171.8M | |
| Property Plant And Equipment | $15.8M | $13.1M | $12.2M | $7.3M | $9.6M | |
| Long-Term Investments | $300K | $300K | $33.4M | $7.6M | $4.1M | |
| Goodwill | $9.8M | $21.5M | $21.5M | $21.5M | $21.5M | |
| Other Intangibles | $3.4M | $10.2M | $8M | $5.2M | $3.3M | |
| Other Long-Term Assets | $708K | $681K | $450K | $29K | $320K | |
| Total Assets | $129.1M | $143.6M | $156.5M | $110.9M | $211.7M | |
| Accounts Payable | $33M | $29.6M | $30.7M | $17.2M | $60M | |
| Accrued Expenses | $2.6M | $5.7M | $4M | $2.3M | $2.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $2.6M | $2.7M | $2.9M | $2.1M | $1.1M | |
| Other Current Liabilities | $2.7M | $3.2M | $1.7M | $1.3M | $2.1M | |
| Total Current Liabilities | $46.8M | $47.4M | $45.4M | $29.9M | $72.6M | |
| Long-Term Debt | $8.1M | $5.5M | $3.5M | $70K | $2.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $58.1M | $58.5M | $49M | $30M | $76.3M | |
| Common Stock | $28K | $30K | $32K | $35K | $36K | |
| Other Common Equity Adj | -$7K | $10K | -$6K | $29K | -- | |
| Common Equity | $71M | $85.1M | $107.5M | $80.9M | $135.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $71M | $85.1M | $107.5M | $80.9M | $135.4M | |
| Total Liabilities and Equity | $129.1M | $143.6M | $156.5M | $110.9M | $211.7M | |
| Cash and Short Terms | $42.9M | $34.9M | $30.8M | $38M | $102.1M | |
| Total Debt | $8.1M | $5.5M | $3.5M | $70K | $2.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $41.8M | $36.6M | $39M | $82.8M | $145.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $44.5M | $50.6M | $27M | $51.6M | $68.2M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $5.5M | $5.3M | -- | -- | -- | |
| Other Current Assets | -- | -- | $4.1M | $5.5M | -- | |
| Total Current Assets | $97.8M | $92.5M | $70.1M | $139.9M | $224M | |
| Property Plant And Equipment | $13.9M | $12.7M | $7.7M | $10.3M | $10.3M | |
| Long-Term Investments | $250K | $28.2M | $8.7M | $4.9M | -- | |
| Goodwill | $21.7M | $21.5M | $21.5M | $21.5M | -- | |
| Other Intangibles | $10.9M | $8.5M | $5.5M | $3.7M | -- | |
| Other Long-Term Assets | $4.3M | $450K | $414K | $320K | -- | |
| Total Assets | $148.5M | $163.8M | $114M | $180.5M | $256.1M | |
| Accounts Payable | $25.1M | $37.1M | $20.6M | $47M | $67.9M | |
| Accrued Expenses | $13.2M | $2.8M | $1.6M | $3M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $2.8M | $3M | $2.7M | $1.2M | -- | |
| Other Current Liabilities | $4.4M | $4M | $2M | $1.8M | -- | |
| Total Current Liabilities | $49.9M | $51.9M | $32M | $60M | $79.5M | |
| Long-Term Debt | $6.2M | $4.2M | $120K | $2.9M | $1.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $62.5M | $56.6M | $32.1M | $62.8M | $81.1M | |
| Common Stock | $29K | $32K | $34K | $36K | $36K | |
| Other Common Equity Adj | $5K | -$41K | -$6K | $105K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $86M | $107.2M | $81.9M | $117.7M | $174.9M | |
| Total Liabilities and Equity | $148.5M | $163.8M | $114M | $180.5M | $256.1M | |
| Cash and Short Terms | $41.8M | $36.6M | $39M | $82.8M | $145.8M | |
| Total Debt | $6.2M | $4.2M | $120K | $2.9M | $1.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$11.2M | -$19.4M | -$24.4M | -$51.3M | $32.2M | |
| Depreciation & Amoritzation | $3.4M | $5.1M | $5.8M | $6.2M | $5.7M | |
| Stock-Based Compensation | $24.2M | $30M | $29M | $24.1M | $20.6M | |
| Change in Accounts Receivable | -$14M | $10.5M | $5.4M | $8.2M | -$40.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10.7M | $7.2M | -$15.8M | -$2.8M | $66.6M | |
| Capital Expenditures | $3.8M | $2.9M | $4.3M | $3.8M | $4.1M | |
| Cash Acquisitions | $14.9M | $16M | -- | -- | -- | |
| Cash From Investing | -$18.8M | -$18.8M | -$4.3M | $9.4M | -$4.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$100K | -$402K | -$1.8M | |
| Cash From Financing | $4.9M | $3.6M | $15.8M | $577K | $1.7M | |
| Beginning Cash (CF) | $42.9M | $34.9M | $30.8M | $38M | $102.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$3.2M | -$8M | -$4.3M | $7.1M | $64.2M | |
| Ending Cash (CF) | $39.7M | $26.8M | $26.5M | $45.1M | $166.3M | |
| Levered Free Cash Flow | $6.8M | $4.3M | -$20.1M | -$6.7M | $62.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$5.3M | -$6.5M | -$29.2M | $11.6M | $18.9M | |
| Depreciation & Amoritzation | $1.3M | $1.4M | $2.3M | $1.6M | $811K | |
| Stock-Based Compensation | $8.3M | $7.2M | $5.6M | $5.4M | $6.7M | |
| Change in Accounts Receivable | $1.4M | -$3.9M | -$63K | -$219K | -$13.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.8M | -$3.5M | -$4.1M | $23.6M | $19.8M | |
| Capital Expenditures | $965K | $1.2M | $966K | $1.5M | $1.3M | |
| Cash Acquisitions | $16M | -- | -- | -- | -- | |
| Cash From Investing | -$16.9M | -$1.2M | $12.2M | -$1.5M | -$1.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $21M | |
| Other Financing Activities | -- | -$28K | -$67K | -$507K | -- | |
| Cash From Financing | $1.4M | $94K | -$67K | -$219K | -$20.9M | |
| Beginning Cash (CF) | $41.8M | $36.6M | $39M | $82.8M | $145.8M | |
| Foreign Exchange Rate Adjustment | -$7K | -$22K | -$13K | $16K | -$5K | |
| Additions / Reductions | -$12.7M | -$4.7M | $8M | $21.9M | -$2.4M | |
| Ending Cash (CF) | $29M | $31.9M | $47M | $104.8M | $143.3M | |
| Levered Free Cash Flow | $1.8M | -$4.8M | -$5.1M | $22.1M | $18.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$14.7M | -$24.4M | -$53.4M | $13.5M | $53.9M | |
| Depreciation & Amoritzation | $4.8M | $5.8M | $6.6M | $5.2M | $4.5M | |
| Stock-Based Compensation | $29.1M | $29.4M | $25.9M | $20.1M | $24M | |
| Change in Accounts Receivable | -$3M | $4M | $17.5M | -$26.1M | -$19.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10.8M | -$17.8M | -$6.9M | $45.6M | $88.5M | |
| Capital Expenditures | $3.4M | $3.8M | $4.1M | $4M | $4.9M | |
| Cash Acquisitions | $16M | -- | -- | -- | -- | |
| Cash From Investing | -$19.3M | -$3.8M | $9.1M | -$4M | -$4.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $21M | |
| Other Financing Activities | -- | -- | -$320K | -$1.5M | -- | |
| Cash From Financing | $4.4M | $16.2M | $232K | $2.1M | -$20.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$4.1M | -$5.4M | $2.5M | $43.8M | $62.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $7.4M | -$21.6M | -$11M | $41.7M | $83.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$11M | -$15.9M | -$44.9M | $19.9M | $41.6M | |
| Depreciation & Amoritzation | $3.6M | $4.3M | $5.1M | $4.1M | $3M | |
| Stock-Based Compensation | $23M | $22.4M | $19.3M | $15.3M | $18.7M | |
| Change in Accounts Receivable | $1.7M | -$4.9M | $7.3M | -$27.1M | -$6.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $14M | -$10.9M | -$2M | $46.4M | $68.4M | |
| Capital Expenditures | $2.3M | $3.2M | $3M | $3.1M | $3.9M | |
| Cash Acquisitions | $16M | -- | -- | -- | -- | |
| Cash From Investing | -$18.2M | -$3.2M | $10.2M | -$3.1M | -$3.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $21M | |
| Other Financing Activities | -- | -$79K | -$299K | -$1.4M | -$2.3M | |
| Cash From Financing | $3.1M | $15.7M | $41K | $1.6M | -$20.8M | |
| Beginning Cash (CF) | $143.2M | $124M | $98.9M | $192.4M | $418.9M | |
| Foreign Exchange Rate Adjustment | -$6K | -$49K | $3K | $12K | $2K | |
| Additions / Reductions | -$1.1M | $1.5M | $8.2M | $44.9M | $43.7M | |
| Ending Cash (CF) | $142.1M | $125.4M | $107.1M | $237.3M | $462.6M | |
| Levered Free Cash Flow | $11.8M | -$14.1M | -$5M | $43.3M | $64.5M | |
Get EVER Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EVER
Sector
P/E ratio
17.30x
16.71x
PEG ratio
0.06x
0.00x
P/B ratio
5.09x
1.30x
Price / LTM sales
1.44x
0.85x
Growth Metrics
EVER
Sector
Revenue growth
20.35%
1.07%
Earnings growth
61.03%
9.09%
Revenue (5-year growth)
14.99%
1.1%
Earnings forecast
$0.66
$0.07
Profitability
EVER
Sector
Profitability FY 2024
$479.3M
$106.1M
Return on invested capital
35.21%
0.43%
Return on assets
24.01%
-0.17%
Return on equity
36.02%
1.42%
Earnings Date
Last Earnings Date
Nov
3
Next Earnings Date
Feb
23
Estimated Next Earnings Date
Feb
2
Balance Sheet
EVER
Sector
Total cash
$145.8M
$68.9M
Short term investments
--
$24.7M
Total assets
$211.7M
$546.7M
Long term debt
$1.6M
$10.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
